- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02926118
Continuous Glucose Monitoring During Diets That Differ in Glycemic Load (GLOW)
October 18, 2017 updated by: Unilever R&D
This study test whether a Continuous Glucose Monitor can pickup differences in glucose (in the interstitial fluid) during a dietary intervention using meals with either a high with a low glycemic load.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to determine the suitability of a continuous glucose monitor to detect the impact of a dietary intervention on postprandial blood glucose levels in normal, healthy, free living subjects.
We will compare a dietary intervention of meals with a high glycemic load (high post-meal blood glucose) versus meals with a low glycemic load (low post-meal blood glucose) in a cross-over study.
In addition, the glucose profiles obtained both via venous blood sampling and via continuous glucose monitor following a standard carbohydrate load will be compared.
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Maastricht, Netherlands
- Maastricht University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Apparently healthy males and post-menopausal females
- Age at start of the study ≥ 50 and ≤ 70 years
- Body mass index (BMI) ≥ 25.0 and ≤ 35.0 kg/m2
- Fasting blood glucose value of subjects is ≥ 3.4 and < 6.1 mmol/L at screening
- Being used to eat three meals a day
- Having a general practitioner
- Agreeing to be informed about medically relevant personal test-results by a physician
- Accessible veins on arms as determined by examination at screening.
Exclusion Criteria:
- Having a medical conditions which might affect the study measurements (including but not limited to: diabetes type 1 and type 2, gastrointestinal disorders, gastrointestinal surgery and inflammatory diseases, as judged by the study physician
- Reported use of over-the-counter or prescribed medication or food supplements, which may interfere with study measurements as judged by the principal investigator
- Use of oral antibiotics in 40 days or less prior to the start of the study
- Reported participation in another nutritional or biomedical study 3 months before the screening or during the study
- Reported participation in night shift work 2 weeks prior to screening or during the study. Night work is defined as working between mid-night and 6.00 am
- Reported intense sporting activities > 2h/w. Intense sporting activities are defined as those activities that cause a lack of breath which limits the ability to have a normal conversation
- Reported alcohol consumption > 10 units/week (female) or > 14 units/week (male)
- Reported use of any nicotine containing products in the 6 months preceding the study and willing to abstain from use of nicotine containing products during the study itself
- Reported dietary habits: medically prescribed diet, slimming diet, vegetarian
- Reported weight loss/gain (> 3 kg) in the last 2 months before the study
- Being an employee of Unilever or research departments in NUTRIM or the Maastricht University Medical Centre (MUMC+) collaborating in this study
- Known allergy or intolerance to food products.
- Blood donation in the past 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low glycemic load
|
Low glycemic load diets will be consumed at breakfast, lunch and dinner for three consecutive days
|
Experimental: High glycemic load
|
High glycemic load diets will be consumed at breakfast, lunch and dinner for three consecutive days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post prandial glucose concentration
Time Frame: 0 - 120 minutes after the start of each of the 3 main meals (breakfast, lunch dinner)
|
Difference in glucose concentrations between the low glycemic load and the high glycemic load diet.
Incremental area under the curve after the three main meals (breakfast, lunch, dinner) during both dietary interventions will be calculated.
The nine post prandial periods for both low and high glycemic load diet per subject will be combined in the mixed model.
|
0 - 120 minutes after the start of each of the 3 main meals (breakfast, lunch dinner)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Three-day glucose concentration
Time Frame: From start of dietary intervention until the end 3 days later
|
Difference in glucose concentrations between the low and the high glycemic load diet.
Total area under the curve will be compared
|
From start of dietary intervention until the end 3 days later
|
Day time glucose concentration
Time Frame: Between 07:00-22:00 h
|
Difference in glucose concentrations between the low and the high glycemic load diet.
Total area under the curve will be compared
|
Between 07:00-22:00 h
|
Night time glucose concentration
Time Frame: Between 22:01-26:59 h
|
Difference in glucose concentrations between the low and the high glycemic load diet.
Total area under the curve will be compared
|
Between 22:01-26:59 h
|
Glucose variability
Time Frame: From start of dietary intervention until the end 3 days later
|
The Continuous Overall Net Glycemic Action (CONGA) will be calculated.
|
From start of dietary intervention until the end 3 days later
|
Comparison of continuous interstitial glucose with venous blood glucose
Time Frame: -30, -15, 15, 30, 45, 60, 90 and 120 minutes after consumption of a standard meal
|
Bland-Altman plots of venous blood glucose plotted against the continuous interstitial glucose at the closest available time point.
Standard meal will be 200 grams of rice consumed on the day after both the low and high glycemic load diets
|
-30, -15, 15, 30, 45, 60, 90 and 120 minutes after consumption of a standard meal
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Carry over of the dietary intervention into the next day
Time Frame: 0 - 120 minutes after the standard meal
|
Difference in glucose (in venous blood) and insulin responses to a standard meal consumed on the day after both the low and high glycemic load diets.
2-hour post prandial Incremental are under the curve for glucose and insulin in venous blood will be calculated.
|
0 - 120 minutes after the standard meal
|
Carry over as measured in venous blood versus as measured during continuous glucose monitoring
Time Frame: 0 - 120 minutes after the standard meal
|
Compare the difference in glucose responses to the standard meal on morning after the low and the high glycemic load diet measured in venous blood with the difference as measured in using continuous blood glucose monitor.
2-hour post prandial incremental area under the curve for glucose will be calculated for both methods.
|
0 - 120 minutes after the standard meal
|
Post prandial glucose concentration during breakfast, lunch or dinner.
Time Frame: 0 - 120 minutes after each of the start of the meal
|
Difference in post prandial glucose concentrations between the low glycemic load and the high glycemic load diet.
Incremental area under the curve after each of the three main meals (breakfast, lunch, dinner) during the three-day dietary interventions will be calculated separately.
The three post prandial periods for both low and high glycemic load diet per subject will be combined in separate mixed models for breakfast, a model for lunch and a model for dinner.
|
0 - 120 minutes after each of the start of the meal
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mensink Ronald P, PhD, Maastricht University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 27, 2017
Primary Completion (Actual)
July 13, 2017
Study Completion (Actual)
October 18, 2017
Study Registration Dates
First Submitted
October 5, 2016
First Submitted That Met QC Criteria
October 5, 2016
First Posted (Estimate)
October 6, 2016
Study Record Updates
Last Update Posted (Actual)
October 19, 2017
Last Update Submitted That Met QC Criteria
October 18, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REF-CSC-2682
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
Solvay PharmaceuticalsTerminatedDyslipidemia | Glucose Metabolism DisorderPoland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
DLR German Aerospace CenterCompletedGlucose Metabolism Disorders | Local Glucose Uptake
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderCzech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
Clinical Trials on Low glycemic load
-
Universidad Autonoma de Baja CaliforniaTerminated
-
Vrije Universiteit BrusselKU LeuvenCompleted
-
University of TorontoActive, not recruiting
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Glucose IntoleranceUnited States
-
Rhode Island HospitalCystic Fibrosis FoundationRecruitingCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
Boston Children's HospitalCompletedCystic Fibrosis | Cystic Fibrosis-related Diabetes | Cystic Fibrosis With Intestinal ManifestationsUnited States
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Beth... and other collaboratorsCompleted
-
Boston Children's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Charles...Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
University of Arkansas, FayettevilleRecruiting